The FDA’s Rare Disease Innovation Hub has released its Strategic Agenda, focusing on advancing regulatory science of rare disease therapies, strengthening coordination between FDA’s Medical Product Centers, and creating a centralized point of contact for external partners.

#FDA #RareDisease #StrategicAgenda
#Innovation #Hub